PD 161570


Related Categories Approved Therapeutics / Drug Candidates, Bioactive Small Molecules Alphabetical Index, Bioactive Small Molecules, Cell Biology, Cell Signaling, and Neuroscience,

Quality level: 100

Assay: ≥98% (HPLC)

Form: dust

mfr. No:  Pfizer®

Color: white to off-white


DMSO :> 10 mg / mL

Creator: Pfizer



5, 25 mg in a glass bottle

Biochemical / Physiological Actions

PD-161570 is a human FGF-1 receptor tyrosine kinase inhibitor.

Features and Benefits

  • This compound is a featured product for phosphatase kinase biology research. Click here to discover more featured phosphatase kinase biology products. Learn more about bioactive small molecules for other research areas at sigma.com/discover-bsm.
  • This compound is also offered as part of Sigma’s Library of Pharmacologically Active Compounds (LOPAC®Pfizer), a collection of 90 drugs and research tools developed by Pfizer. Click here to find out more.
  • This compound is listed on the FGFR page of the Signal Transduction and Receptor Classification Manual. To browse other pages in the manual, click here.

Other notes

This compound was developed by Pfizer for phosphatase kinase biology research. To learn more about Sigma’s partnership with Pfizer and to view other high-quality, authentic Pfizer compounds, visit sigma.com/bsm-pfizer. To browse the list of other pharmaceutical industry-developed compounds and approved drugs/drug candidates, click here.

Legal information

  • It is sold for research purposes under the agreement of Pfizer Inc.
  • LOPAC is a registered trademark of Sigma-Aldrich Co. LLC
  • Pfizer is a registered trademark of Pfizer, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *


Monkey Tumor necrosis factor

Product name: Recombinant (active) mouse TNF alpha protein Biological activity Fully active compared to a standard. The ED50 determined by the dose-dependent killing/apoptosis of L-929 cells is 1.12 ng / ml corresponding to a specific activity of 8.93 x 105 IU / mg. Purity: = 95% SDS-PAGE. Purity by HPLC> = 95%. Endotoxin Level: <0.005 […]

Read More


Resume Background Sepsis is a potentially fatal syndrome mediated by an early [eg, tumor necrosis factor-alpha (TNF-α)] and late [high-mobility group box 1 (HMGB-1)] cytokine response to infection. Sepsis-induced acute kidney injury (ARI) is associated with high mortality. C-Fos / activator protein-1 (AP-1) controls the transactivation of pro-inflammatory cytokines through the binding of AP-1 in […]

Read More

AVE 0991

Description AVE 0991 is an orally active, non-peptide angiotensin (1-7) receptor agonist with an IC50 of 21 nM. IC50 and target IC50: 21 ± 35 nM (receptor Ang- (1-7)) In vitro AVE 0991 is a non-peptide compound that evokes Ang- (1-7) -like effects on the endothelium. AVE 0991 and unlabeled Ang- (1-7) compete for high-affinity […]

Read More